Silver-bullet jubilee
FOR all the buzz that surrounds biotechnology, you might imagine it was a brand new science. In fact, it is old: so old, indeed, that one of the cornerstones of modern biotech, the monoclonal antibody, celebrated its 25th birthday on August 7th. When César Milstein and Georges Köhler, two researchers at the Laboratory of Molecular Biology in Cambridge, England, first published a way to produce highly specific antibodies in a test tube, they speculated that it might have some commercial value. But as Dr Milstein points out, they never imagined their invention would grow into a multi-billion dollar market used to diagnose and, more recently to treat, disease.
This article appeared in the Science & technology section of the print edition under the headline “Silver-bullet jubilee”
Discover more
Elon Musk is causing problems for the Royal Society
His continued membership has led to a high-profile resignation
Deforestation is costing Brazilian farmers millions
Without trees to circulate moisture, the land is getting hotter and drier
Robots can learn new actions faster thanks to AI techniques
They could soon show their moves in settings from car factories to care homes
Scientists are learning why ultra-processed foods are bad for you
A mystery is finally being solved
Scientific publishers are producing more papers than ever
Concerns about some of their business models are building
The two types of human laugh
One is caused by tickling; the other by everything else